A. H. Corner

2.9k total citations
81 papers, 2.2k citations indexed

About

A. H. Corner is a scholar working on Molecular Biology, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, A. H. Corner has authored 81 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Epidemiology and 14 papers in Animal Science and Zoology. Recurrent topics in A. H. Corner's work include Fatty Acid Research and Health (14 papers), Diabetes Treatment and Management (10 papers) and Lipid metabolism and biosynthesis (9 papers). A. H. Corner is often cited by papers focused on Fatty Acid Research and Health (14 papers), Diabetes Treatment and Management (10 papers) and Lipid metabolism and biosynthesis (9 papers). A. H. Corner collaborates with scholars based in Finland, Canada and Sweden. A. H. Corner's co-authors include Hannele Yki‐Järvinen, J. K. G. Kramer, Mathijs C. Bunck, Björn Eliasson, Ulf Smith, Robert J. Heine, Michaëla Diamant, Marja‐Riitta Taskinen, Rimma M. Shaginian and D. Mitchell and has published in prestigious journals such as Diabetes Care, Radiology and Journal of Clinical Microbiology.

In The Last Decade

A. H. Corner

75 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. H. Corner Finland 25 899 617 530 521 290 81 2.2k
Carla Portocarrero United States 19 171 0.2× 926 1.5× 326 0.6× 188 0.4× 885 3.1× 31 2.4k
Lindsey Inman United States 23 414 0.5× 583 0.9× 98 0.2× 710 1.4× 76 0.3× 35 1.7k
Kosuke Okada Japan 26 142 0.2× 1.1k 1.9× 698 1.3× 255 0.5× 59 0.2× 125 2.5k
Erik Eckhardt United States 21 165 0.2× 860 1.4× 324 0.6× 461 0.9× 237 0.8× 40 1.8k
David G. Besselsen United States 32 85 0.1× 1.2k 2.0× 330 0.6× 365 0.7× 192 0.7× 83 3.0k
Kabirou Moutaïrou Benin 23 170 0.2× 315 0.5× 178 0.3× 166 0.3× 207 0.7× 61 1.8k
Rebecca A. Owens Ireland 19 146 0.2× 1.9k 3.0× 365 0.7× 227 0.4× 117 0.4× 47 2.7k
Ivar Lönnroth Sweden 27 80 0.1× 1.1k 1.8× 243 0.5× 284 0.5× 324 1.1× 89 2.7k
Luis Fontana Spain 22 120 0.1× 1.0k 1.7× 621 1.2× 205 0.4× 355 1.2× 46 2.1k
John D. Williams United States 12 81 0.1× 222 0.4× 313 0.6× 371 0.7× 800 2.8× 33 1.6k

Countries citing papers authored by A. H. Corner

Since Specialization
Citations

This map shows the geographic impact of A. H. Corner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. H. Corner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. H. Corner more than expected).

Fields of papers citing papers by A. H. Corner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. H. Corner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. H. Corner. The network helps show where A. H. Corner may publish in the future.

Co-authorship network of co-authors of A. H. Corner

This figure shows the co-authorship network connecting the top 25 collaborators of A. H. Corner. A scholar is included among the top collaborators of A. H. Corner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. H. Corner. A. H. Corner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muskiet, Marcel H.A., Mathijs C. Bunck, Robert J. Heine, et al.. (2019). Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial. Diabetes Research and Clinical Practice. 153. 14–22. 18 indexed citations
2.
Raalte, Daniël H. van, Mathijs C. Bunck, Mark M. Smits, et al.. (2016). Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial. European Journal of Endocrinology. 175(4). 345–352. 24 indexed citations
3.
Corner, A. H., Kati Kaartinen, Sari Aaltonen, et al.. (2012). Membranoproliferative glomerulonephritis complicatingPropionibacterium acnesinfection. Clinical Kidney Journal. 6(1). 35–39. 2 indexed citations
4.
Sevastianova, Ksenia, Antti Hakkarainen, Anna Kotronen, et al.. (2010). Nonalcoholic Fatty Liver Disease: Detection of Elevated Nicotinamide Adenine Dinucleotide Phosphate with in Vivo 3.0-T31P MR Spectroscopy with Proton Decoupling. Radiology. 256(2). 466–473. 43 indexed citations
5.
Bunck, Mathijs C., A. H. Corner, Björn Eliasson, et al.. (2010). Extended, 3-year, exenatide therapy shows sustainable effects on beta cell disposition index in metformin treated patients with type 2 diabetes. Pure Amsterdam UMC. 53. 2 indexed citations
6.
Kotronen, Anna, Leena Juurinen, Antti Hakkarainen, et al.. (2007). Liver Fat Is Increased in Type 2 Diabetic Patients and Underestimated by Serum Alanine Aminotransferase Compared With Equally Obese Nondiabetic Subjects. Diabetes Care. 31(1). 165–169. 152 indexed citations
7.
Makkonen, Janne, Jukka Westerbacka, Maria Kolak, et al.. (2007). Increased expression of the macrophage markers and of 11β-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity. International Journal of Obesity. 31(10). 1617–1625. 34 indexed citations
8.
Westerbacka, Jukka, A. H. Corner, Katja Kannisto, et al.. (2005). Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects. Diabetologia. 49(1). 132–140. 47 indexed citations
9.
Prentice, AM, et al.. (2004). A patient support programme for orlistat - Analysis of adherence and weight loss. International Journal of Obesity. 28. 1 indexed citations
10.
Farnworth, Edward R., J. K. G. Kramer, B. K. Thompson, & A. H. Corner. (1982). Role of Dietary Saturated Fatty Acids on Lowering the Incidence of Heart Lesions in Male Rats. Journal of Nutrition. 112(2). 231–240. 20 indexed citations
11.
Dukes, T. W., A. S. Greig, & A. H. Corner. (1980). Maedi Visna in Canadian Sheep. Journal of the American Veterinary Medical Association. 176(9). 926–926. 13 indexed citations
12.
Kramer, J. K. G., et al.. (1979). Cardiopathogenicity of soybean oil and tower rapessed oil triglycerides when fed to male rats. Lipids. 14(9). 773–780. 13 indexed citations
13.
HULAN, H.W., J. K. G. Kramer, & A. H. Corner. (1977). Myocardial lesions in rats fed rapeseed oil. I. Influence of strain of rats. Canadian Journal of Physiology and Pharmacology. 55(2). 258–264. 20 indexed citations
14.
Mitchell, D., et al.. (1976). Meningoencephalomyelitis in Horses Associated with Equine Herpesvirus 1 Infection. Veterinary Pathology. 13(1). 59–68. 52 indexed citations
15.
Corner, A. H. & K W Jericho. (1972). Pneumonia Associated with Inhaled Plant Material in Swine. Veterinary Pathology. 9(5). 384–391. 3 indexed citations
16.
Corner, A. H.. (1968). Textbook of the Special Pathological Anatomy of Domestic Animals. Canadian veterinary journal. 9(11). 259–259. 1 indexed citations
17.
Corner, A. H., et al.. (1966). Induced tolerance in turkeys to aflatoxin poisoning.. PubMed. 30(1). 17–25. 5 indexed citations
18.
Mitchell, D., et al.. (1966). Some observations on the diagnosis and epidemiology of leptospirosis in swine.. PubMed. 30(8). 211–7. 11 indexed citations
19.
Corner, A. H., et al.. (1959). Xanthomatosis In White Leghorns In Canada.. PubMed. 23(6). 199–202. 2 indexed citations
20.
Corner, A. H., et al.. (1959). XI. Search For Inclusion Bodies During The Development Of Atrophic Rhinitis In Artifically Infected Pigs.. PubMed. 23(3). 84–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026